Galera Therapeutics, Inc.
GRTX
$0.09
$0.00-4.61%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.50M | 6.38M | 4.47M | 5.23M | 6.69M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 563.00K | 720.00K | 428.00K | 717.00K | 874.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 6.06M | 7.10M | 4.90M | 5.95M | 7.56M |
|
|
|||||
| Total Current Assets | 6.06M | 7.10M | 4.90M | 5.95M | 7.56M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 101.00K | 101.00K | 101.00K | 101.00K | 101.00K |
| Total Assets | 6.16M | 7.20M | 5.00M | 6.05M | 7.66M |
|
|
|||||
| Total Accounts Payable | 699.00K | 265.00K | 434.00K | 202.00K | 744.00K |
| Total Accrued Expenses | 298.00K | 380.00K | 164.00K | 145.00K | 231.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 144.00K | -- | -- | -- | -- |
| Total Other Current Liabilities | 144.00K | -- | -- | -- | -- |
| Total Current Liabilities | 1.14M | 645.00K | 598.00K | 347.00K | 975.00K |
|
|
|||||
| Total Current Liabilities | 1.14M | 645.00K | 598.00K | 347.00K | 975.00K |
| Long-Term Debt | -- | -- | 151.05M | 151.05M | 151.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.14M | 645.00K | 151.65M | 151.40M | 152.02M |
|
|
|||||
| Common Stock & APIC | 309.65M | 311.29M | 311.20M | 311.09M | 310.73M |
| Retained Earnings | -308.92M | -307.31M | -460.42M | -459.03M | -457.96M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 728.00K | 3.97M | -149.22M | -147.95M | -147.23M |
|
|
|||||
| Preferred Stock Redeemable | 4.30M | 2.58M | 2.58M | 2.60M | 2.86M |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 4.30M | 2.58M | 2.58M | 2.60M | 2.86M |
|
|
|||||
| Total Common Equity | 728.00K | 3.97M | -149.22M | -147.95M | -147.23M |
| Total Preferred Equity | 4.30M | 2.58M | 2.58M | 2.60M | 2.86M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.02M | 6.55M | -146.65M | -145.35M | -144.36M |
|
|
|||||